美国证券交易委员会 (SEC) 文件显示，Vaxcyte 首席运营官 Jim Wassil 于 6 月 3 日以每股 71.99 美元的价格出售了 3,000 股股票。 Vaxcyte COO Jim Wassil sold 3,000 shares at $71.99 per share on June 3rd, SEC filing.

Vaxcyte 首席运营官 Jim Wassil 于 6 月 3 日以 215,970 美元的价格出售了 3,000 股公司股票，剩下 213,503 股，价值 1,537 万美元。 Vaxcyte COO Jim Wassil sold 3,000 shares of the company's stock for $215,970 on June 3rd, leaving him with 213,503 shares worth $15.37M. 这些股票的平均售价为 71.99 美元。 The shares were sold at an average price of $71.99. 此次出售已在提交给美国证券交易委员会的文件中进行了披露。 The sale was reported in a filing with the SEC. Vaxcyte 的股票 50 天和 200 天 SMA 分别为 66.41 美元和 65.64 美元，52 周范围为 44.20 美元至 82.04 美元。 Vaxcyte's stock had a 50-day and 200-day SMA of $66.41 and $65.64, and its 52-week range is $44.20-$82.04. Vaxcyte 最新公布的每股收益为 -0.85 美元，超出预期 0.28 美元。 Vaxcyte last posted earnings of ($0.85) EPS, exceeding the estimate by $0.28.